Novel GM-CSF signals via IFN-γR/IRF-1 and AKT/mTOR license monocytes for suppressor function
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Key Points: Novel GM-CSF signaling pathways through IFN-γR/IRF-1 and AKT/mTOR provide monocyte licensing for suppressor function. Only licensed but not fresh Ly-6Chigh murine or human CD14+ monocytes secrete nitric oxide or IDO for T-cell suppression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544 · cited 2×
“Monocytes are essential for protective immunity during acute infections and can augment autoimmune reactions,(1) whereas monocytic suppressor cells interfere with immune responses against tumors and chronic infections.(2,3) Both inflammatory monocytes and monocytic suppressor cells can generate Nitric oxide (NO) via t…”
BackgroundNitric oxide and the immune response
Bogdan, C. (2001) · Nature Immunology · doi:10.1038/ni1001-907 · Cited by 3,447
Self-citationRegulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775 · cited 2×
“Thus, although the same signaling machinery is used to initiate suppression of human and mouse monocytes, the final effector strategies differ in the use of enzymes catabolizing either arginine or tryptophan to induce metabolic starvation of T cells.(4,56) In conclusion, we identified novel signaling pathways of GM-CS…”
BackgroundIRF Family of Transcription Factors as Regulators of Host Defense
Taniguchi, T., Ogasawara, K., Takaoka, A., & Tanaka, N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.623 · Cited by 1,658
Colony-stimulating factors in inflammation and autoimmunity
Hamilton, J. A. (2008) · Nature reviews. Immunology · doi:10.1038/nri2356 · Cited by 1,305 · cited 3×
“Discussion There are numerous examples of anti-inflammatory(43) or proinflammatory activity of GM-CSF.(30) The evolutionarily developed role of suppressor monocytes is presumably to limit evolving T-cell responses against pathogenic challenges.”
BackgroundInfluentialCodarri, L., Gyülvészi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T., & Becher, B. (2011) · Nature Immunology · doi:10.1038/ni.2027 · Cited by 1,191 · cited 2×
“Others have shown that GM-CSF production by Th17 and Th1 cells during the effector phase of EAE exacerbates the clinical symptoms by stimulating myeloid cell infiltrates into the central nervous system, which can be reversed by GM-CSF blockade.(44,45) Importantly, GM-CSF signaling in monocytes was critical for their d…”
BackgroundEl-Behi, M., Ciric, B., Dai, H., Yan, Y., Cullimore, M., Safavi, F., Zhang, G.-X., Dittel, B. N., & Rostami, A. (2011) · Nature Immunology · doi:10.1038/ni.2031 · Cited by 1,071 · cited 2×
“Others have shown that GM-CSF production by Th17 and Th1 cells during the effector phase of EAE exacerbates the clinical symptoms by stimulating myeloid cell infiltrates into the central nervous system, which can be reversed by GM-CSF blockade.(44,45) Importantly, GM-CSF signaling in monocytes was critical for their d…”
BackgroundIndoleamine 2,3 dioxygenase and metabolic control of immune responses
Munn, D. H., & Mellor, A. L. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.10.001 · Cited by 1,037 · cited 1×
“Thus, although the same signaling machinery is used to initiate suppression of human and mouse monocytes, the final effector strategies differ in the use of enzymes catabolizing either arginine or tryptophan to induce metabolic starvation of T cells.(4,56) In conclusion, we identified novel signaling pathways of GM-CS…”
BackgroundNitric oxide synthase in innate and adaptive immunity: an update
Bogdan, C. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.01.003 · Cited by 862
Self-citationThe Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity
Croxford, A. L., Lanzinger, M., Hartmann, F. J., Schreiner, B., Mair, F., Pelczar, P., Clausen, B. E., Jung, S., Greter, M., & Becher, B. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.010 · Cited by 484
Cited by
Myeloid-derived suppressor cells coming of age
Veglia, F., Perego, M., & Gabrilovich, D. (2018) · Nature Immunology · doi:10.1038/s41590-017-0022-x · Cited by 1,767
The dual nature of type I and type II interferons
Lee, A. J., & Ashkar, A. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02061 · Cited by 690
MDSC: Markers, development, states, and unaddressed complexity
Hegde, S., Leader, A. M., & Merad, M. (2021) · Immunity · doi:10.1016/j.immuni.2021.04.004 · Cited by 669
Gulley, J. L., Borre, M., Vogelzang, N. J., Ng, S., Agarwal, N., Parker, C. C., Pook, D. W., Rathenborg, P., Flaig, T. W., Carles, J., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02031 · Cited by 285
GM-CSF: A Double-Edged Sword in Cancer Immunotherapy
Kumar, A., Taghi Khani, A., Sanchez Ortiz, A., & Swaminathan, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.901277 · Cited by 265
Metadata
- Authors
- Ribechini, E., Hutchinson, J. A., Hergovits, S., Heuer, M., Lucas, J., Schleicher, U., Jordán Garrote, A.-L., Potter, S. J., Riquelme, P., Brackmann, H., Müller, N., Raifer, H., Berberich, I., Huber, M., Beilhack, A., Lohoff, M., Bogdan, C., Eyrich, M., Hermanns, H. M., Geissler, E. K., & Lutz, M. B.
- Venue
- Blood Advances
- Publisher
- American Society of Hematology
- Published
- 2017-06-07
- Volume
- 1
- Issue
- 14
- Pages
- 947-960
- ISSN
- 2473-9529 (ISSN-L)
- 2473-9537
- OpenAlex
- W2733188787
- Cited by
- 94
- References
- 10
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Novel GM-CSF signals via IFN-γR/IRF-1 and AKT/mTOR license monocytes for suppressor function. https://app.cochat.ai/papers/10.1182/bloodadvances.2017006858
- The paper
- Ribechini, E., Hutchinson, J. A., Hergovits, S., Heuer, M., Lucas, J., Schleicher, U., Jordán Garrote, A.-L., Potter, S. J., Riquelme, P., Brackmann, H., Müller, N., Raifer, H., Berberich, I., Huber, M., Beilhack, A., Lohoff, M., Bogdan, C., Eyrich, M., Hermanns, H. M., . . . Lutz, M. B. (2017). Novel GM-CSF signals via IFN-γR/IRF-1 and AKT/mTOR license monocytes for suppressor function. Blood Advances. https://doi.org/10.1182/bloodadvances.2017006858
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.